Anaplastic Astrocytoma - 215 Studies Found
Completed |
: Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) :
: 2009-08-26 : Drug: Super-Selective Intraarterial Intracranial Infusion of BEVACIZUMAB |
Recruiting |
: Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA :
: 2010-12-22 :
|
Active, not recruiting |
: P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA :
: 2015-04-03 :
|
Completed |
: Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma : Adult Brain Tumor : 1999-11-01 : Drug: Antineoplaston therapy (Atengenal + Astugenal) Adults with an anaplastic astrocytoma will receive |
Completed |
: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma : Brain and Central Nervous System Tumors : 1999-11-01 :
|
Active, not recruiting |
: Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas : Brain and Central Nervous System Tumors : 2000-01-28 :
|
Completed |
: Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse : Brain and Central Nervous System Tumors : 1999-11-01 : Drug: leflunomide |
Completed |
: Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma :
|
Terminated |
: Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas :
: 2006-08-03 :
|
Completed |
: Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA :
: 2010-11-04 : Drug: Superselective Intraarterial Cerebral Infusion of Cetuximab Intraarterial Mannitol 25% 3-10 ml to |